Introduction to Multiplex Imaging

Definition and Scope

Multiplex imaging refers to the simultaneous detection and visualization of multiple molecular targets within a single biological sample. It broadens the scope of information that can be collected from a biological sample at once.¹ Related concepts include:

• High-plex imaging: The ability to detect dozens or hundreds of markers in one assay, providing a comprehensive molecular profile²
• Multi-channel imaging: Acquisition of multiple optical channels (fluorescence, brightfield or other modalities) with multiple detectors or filters to visualize distinct markers simultaneously³
• Multi-omics imaging: Integration of different molecular layers, such as transcriptomics, proteomics and metabolomics, within the spatial context of tissues⁴

Technological Evolution

The complex and heterogeneous composition of tissue and tumor microenvironments required a progression from single-marker assays, which detect one protein or molecule at a time, to multi-target detection platforms capable of analyzing numerous molecules simultaneously. Simultaneously, advances in spatial biology, immunofluorescence and imaging methods have empowered detailed localization of biomolecules within intact cellular and tissue architectures. These innovations demonstrate significant potential for clinical diagnostics and translational research by accelerating biomarker discovery and patient stratification and fostering a deeper understanding of complex biological systems.¹

Types and Modalities of Multiplex Imaging

Optical and Fluorescence-Based Imaging

Optical multiplex imaging captures multiple signals from different molecular markers using high-spatial-resolution light-based detection methods. It is frequently used in routine histology workflows.⁵ On the other hand, fluorescence imaging visualizes multiple markers using several fluorophores with different excitation/emission spectra. Fluorophores with overlapping spectra are addressed using spectral unmixing techniques to separate signals, thereby improving accuracy and sensitivity.⁶

Varieties of optical and fluorescence-based multiplex imaging include:

• Confocal multiplex imaging, which enhances resolution and reduces background by optically sectioning thick samples with a pinhole-based detection system⁷
• 3D multiplex imaging, which extends confocal or light-sheet microscopy into spatial analysis, allowing precise mapping of markers within intact specimens⁸
• Whole-slide multiplex immunofluorescence (mIF) empowers high-throughput analysis of entire tissue slides, facilitating biomarker quantification and spatial pattern analysis in clinical and research applications⁹

Label-Based Multiplexing

Label-based multiplexing involves tagging techniques for the simultaneous detection of multiple markers. Types of label-based multiplex imaging are:

• Antibody-based multiplex imaging with tagged antibodies to detect multiple markers ¹⁰
• Multiplex immunofluorescence (mIF) using multiple fluorophores for simultaneous detection ¹¹
• Multiplex immunohistochemistry (mIHC) using chromogens that produce color upon a physical or chemical alteration¹²
• Cyclic immunofluorescence and iterative staining multiplexing use repeated staining, bleaching and imaging cycles to streamline the analysis of diverse tissue samples¹³

Mass Spectrometry Multiplex Imaging

Combining mass spectrometry with multiplex imaging enables the spatial mapping of multiple biomarkers in tissue microenvironments. Imaging mass cytometry is one such integrative method that applies metal-tagged antibodies to detect high numbers of biomarkers. Using metal-tagged antibodies instead of fluorophores eliminates the risk of interference from spectral overlap or autofluorescence. Mass spectrometry imaging (MSI) employs molecular mass-based detection to analyze the spatial distribution of various molecular species. These methods allow quantification of multiple proteins and their visualization, revealing significant structural details, such as post-translational modifications.⁴

Comparing Multiplex Imaging Approaches

Each detection approach trades plex count against throughput and tissue preservation differently. The table below summarizes those trade-offs at a category level.

Featured Product

Choosing Between Multiplex Imaging Approaches

The optimal multiplex imaging approach depends on the study's goals, required plex level, throughput needs and sample characteristics. Optical and fluorescence-based methods are often preferred for high-throughput studies across large cohorts. At the same time, mass spectrometry-based approaches can enable higher-plex molecular analysis and avoid issues such as spectral overlap. Cyclic and iterative staining methods are commonly used when studies require expanded marker capacity while preserving spatial context, although they typically involve more complex workflows.

Omics-Integrated and High-Plex Imaging

Multiplex imaging can integrate transcriptomics, proteomics and metabolomics data to map RNA, proteins and metabolites with spatial context. Omics-integrated high-plex imaging facilitates the mapping of thousands of markers in tissue sections, providing insight into tissue microenvironments.¹⁴

Supporting Technologies and Key Concepts

Several technologies form the backbone of multiplex imaging.

Many multiplex imaging modalities rely on highly specific antibodies to target biomarkers through conjugation to detectable tags, such as chromogens, fluorophores and metals.¹⁰ Furthermore, high-throughput proteomics can quantify and localize proteins across tissues at single-cell resolution.¹⁵ Pipelines combining proteomics and multiplex imaging streamline several steps, starting with image acquisition and preprocessing, segmentation and feature extraction and followed by statistical or machine learning–based analyses. These pipelines should emphasize robustness and reproducibility, especially for clinical diagnostic applications, but must be flexible enough to accommodate high throughput for large-scale research and clinical applications.¹⁶

Complexities and Challenges in Image Analysis

Multiplex imaging generates rich, high-dimensional datasets, but extracting reproducible biological insights requires sophisticated image processing, computational analysis and workflow standardization.

High-Dimensional Data Analysis

Multiplex imaging can generate data for dozens or even hundreds of biomarkers per sample, creating challenges in interpretation and analysis. Specialized computational tools are needed to account for signal overlap, tissue heterogeneity and sample variability.¹⁷

Clustering, phenotyping and quantitative imaging methods help researchers identify cell populations and analyze marker expression, co-localization and spatial relationships.¹⁸

Spatial Analysis and Reproducibility

Analyzing biomarker distributions across tissues requires image registration, segmentation and quantification workflows that can be computationally intensive. Variability in staining protocols, imaging platforms and analysis software can also affect reproducibility and cross-study comparisons, making workflow standardization essential.¹⁹

Researchers must address several technical and operational challenges throughout the workflow:

• Imaging artifacts such as autofluorescence, uneven illumination and tissue distortion
• Staining optimization to minimize signal bleed-through and maximize marker specificity
• Assay development through iterative refinement of antibody panels and fluorophore combinations
• Workflow standardization from sample preparation through image analysis and segmentation

Advanced Computational Technologies

AI/ML technologies automate multiplex imaging and enhance data interpretation.¹⁸ Deep learning and CNNs analyze tissue structures for automated segmentation and pattern recognition.²¹ AI/ML methods interpret high-dimensional multiplex data, classify cell types and uncover phenotypic patterns, crucial for patient stratification. Combining AI/ML with quantitative imaging enhances reproducibility and cross-study comparability.¹⁸ Collectively, AI-driven analysis of multiplex imaging data cultivates model robustness, reduces variability and facilitates translation of the findings into clinical settings.

Applications of Multiplex Imaging

Cellular Analysis and Phenotyping

Multiplex imaging can improve biomarker research and target discovery by generating detailed cell phenotyping and classification. This helps researchers distinguish cell types and states within complex tissues. Multiplexed protein marker analysis and quantification can reveal comprehensive information about tissue microenvironments, advancing our understanding of cell–cell interactions and tissue heterogeneity.¹

Oncology and Tumor Microenvironment

Multiplex imaging is particularly valuable in oncology, as tumor development relies heavily on the interplay among tumor cells and other components within the distinctly heterogeneous tumor microenvironment (TME).¹⁷ Multiplex analysis can reveal immune response patterns, as the biomarkers on different immune cells indicate whether they exhibit activating (i.e., cytotoxic) or immunosuppressive phenotypes. These insights guide researchers when designing and optimizing immunotherapy strategies.²²

Clinical Diagnostics and Pathology

In clinical settings, multiplex imaging improves the accuracy and level of detail from tissue biomarker and section analysis, which is essential for precision diagnostics. Simultaneously, several markers can be discovered and analyzed, helping clinicians conduct therapeutic response profiling and patient stratification.²³

Conclusion

Multiplex imaging harbors tremendous research and clinical benefits. Detecting multiple biomarkers within a single tissue sample supports a more holistic view of disease mechanisms and patient-specific tissue models, unlike reductionist single-marker assays. Thus, it improves diagnostic accuracy and predictive power when monitoring patient responses to targeted therapies and immunotherapies.

Pipelines integrating multiplex imaging can close the gap between research and clinic, streamlining the translation of biomarker discovery into diagnostics and therapeutic evaluation. These workflows show great promise for advancing precision medicine.

References

1. Semba T, Ishimoto T. Spatial analysis by current multiplexed imaging technologies for the molecular characterisation of cancer tissues. Br J Cancer 2024;131(11):1737-1747.
2. Aung TN, Bates KM, Rimm DL. High-plex assessment of biomarkers in tumors. Mod Pathol 2024;37(3):100425.
3. Arridge SR, Ehrhardt MJ, Thielemans K. (An overview of) Synergistic reconstruction for multimodality/multichannel imaging methods. Philos Trans R Soc A 2021;379(2200):20200205.
4. Zhang H, Lu KH, Ebbini M, Huang P, Lu H, Li L. Mass spectrometry imaging for spatially resolved multi-omics molecular mapping. npj Imaging 2024;2(1):20.
5. Ugolini F, Pasqualini E, Simi S, Baroni G, Massi D. Bright-field multiplex immunohistochemistry assay for tumor microenvironment evaluation in melanoma tissues. Cancers (Basel) 2022;14(15):3682.
6. Chen K, Yan R, Xiang L, Xu K. Excitation spectral microscopy for highly multiplexed fluorescence imaging and quantitative biosensing. LSA 2021;10(1):97.
7. Lochhead JJ, Williams EI, Reddell ES, Dorn E, Ronaldson PT, Davis TP. High resolution multiplex confocal imaging of the neurovascular unit in health and experimental ischemic stroke. Cells 2023;12(4):645.
8. Cho W, Kim S, Park Y-G. Towards multiplexed immunofluorescence of 3D tissues. Mol Brain 2023;16(1):37.
9. Doyle J, Green BF, Eminizer M, Jimenez-Sanchez D, Lu S, Engle EL, et al. Whole-Slide Imaging, Mutual Information Registration for Multiplex Immunohistochemistry and Immunofluorescence. Lab Invest 2023;103(8):100175.
10. Hickey JW, Neumann EK, Radtke AJ, Camarillo JM, Beuschel RT, Albanese A, et al. Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging. Nat Methods 2022;19(3):284-295.
11. Sheng W, Zhang C, Mohiuddin T, Al-Rawe M, Zeppernick F, Falcone FH, et al. Multiplex immunofluorescence: a powerful tool in cancer immunotherapy. Int J Mol Sci 2023;24(4):3086.
12. Harms PW, Frankel TL, Moutafi M, Rao A, Rimm DL, Taube JM, et al. Multiplex immunohistochemistry and immunofluorescence: a practical update for pathologists. Mod Pathol 2023;36(7):100197.
13. Eng J, Bucher E, Hu Z, Zheng T, Gibbs SL, Chin K, et al. A framework for multiplex imaging optimization and reproducible analysis. Commun Biol 2022;5(1):438.
14. Carstens JL, Krishnan SN, Rao A, Sorace AG, Seeley EH, Ferri-Borgogno S, et al. Spatial multiplexing and omics. Nat Rev Methods Primers 2024;4(1):54.
15. Mund A, Brunner A-D, Mann M. Unbiased spatial proteomics with single-cell resolution in tissues. Mol Cell 2022;82(12):2335-2349.
16. Zahumensky J, Malinsky J. Live cell fluorescence microscopy—an end-to-end workflow for high-throughput image and data analysis. Biol Methods Protoc 2024;9(1):bpae075.
17. Liu K, Liu F, Li G, Zheng Y. Multiplex imaging analysis of the tumor immune microenvironment for guiding precision immunotherapy. Front Immunol 2025;16:1617906.
18. Parra ER, Ilié M, Wistuba II, Hofman P. Quantitative multiplexed imaging technologies for single-cell analysis to assess predictive markers for immunotherapy in thoracic immuno-oncology: promises and challenges. Br J Cancer 2023;129(9):1417-1431.
19. Wilson CM, Ospina OE, Townsend MK, Nguyen J, Moran Segura C, Schildkraut JM, et al. Challenges and opportunities in the statistical analysis of multiplex immunofluorescence data. Cancers (Basel) 2021;13(12):3031.
20. Windhager J, Zanotelli VRT, Schulz D, Meyer L, Daniel M, Bodenmiller B, et al. An end-to-end workflow for multiplexed image processing and analysis. Nat Protoc 2023;18(11):3565-3613.
21. Zidane M, Makky A, Bruhns M, Rochwarger A, Babaei S, Claassen M, et al. A review on deep learning applications in highly multiplexed tissue imaging data analysis. Front Bioinform 2023;3:1159381.
22. Zhao C, Germain RN. Multiplex imaging in immuno-oncology. J ImmunoTher Cancer 2023;11(10):e006923.
23. Bollhagen A, Bodenmiller B. Highly multiplexed tissue imaging in precision oncology and translational cancer research. Cancer Discov 2024;14(11):2071-2088.